KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Minority Interest (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Minority Interest for 13 consecutive years, with $931.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 2.72% to $931.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $931.0 million through Dec 2025, down 2.72% year-over-year, with the annual reading at $931.0 million for FY2025, 2.72% down from the prior year.
  • Minority Interest hit $931.0 million in Q4 2025 for Bausch Health Companies, up from $921.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $958.0 million in Q3 2022 to a low of $69.0 million in Q3 2021.
  • Historically, Minority Interest has averaged $723.4 million across 5 years, with a median of $937.0 million in 2023.
  • Biggest five-year swings in Minority Interest: surged 1288.41% in 2022 and later decreased 3.9% in 2025.
  • Year by year, Minority Interest stood at $72.0 million in 2021, then soared by 1222.22% to $952.0 million in 2022, then decreased by 1.26% to $940.0 million in 2023, then grew by 1.81% to $957.0 million in 2024, then decreased by 2.72% to $931.0 million in 2025.
  • Business Quant data shows Minority Interest for BHC at $931.0 million in Q4 2025, $921.0 million in Q3 2025, and $911.0 million in Q2 2025.